Literature DB >> 943576

Influenza virus RNA's in the cytoplasm of chicken embryo cells treated with 3'-deoxyadenosine.

C L Pridgen.   

Abstract

3'-Deoxyadenosine (75 to 100 mug/ml) permitted analysis of the cytoplasmic influencza virus-specific RNAs synthesized early in the replicative cycle-a phase that has hitherto been obscurred by host cell RNA synthesis. In addition, late in the cycle (6 to 8) complementary virus-specific RNA's were the predominantly labeled species, suggesting that higher concentrations of 3'-deoxyadenosine selectively inhibit influenza viral genome replication.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 943576      PMCID: PMC515554     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  15 in total

1.  Temporal control of transcription of influenza virus RNA.

Authors:  R J Avery; N J Dimmock
Journal:  Virology       Date:  1975-04       Impact factor: 3.616

2.  Adenylate-rich sequences in Sendai virus transcripts from infected cells.

Authors:  C Pridgen; D W Kingsbury
Journal:  J Virol       Date:  1972-08       Impact factor: 5.103

3.  Influenza viral messenger RNA.

Authors:  P R Etkind; R M Krug
Journal:  Virology       Date:  1974-11       Impact factor: 3.616

4.  Cytoplasmic and nucleoplasmic viral RNPs in influenza virus-infected MDCK cells.

Authors:  R M Krug
Journal:  Virology       Date:  1972-10       Impact factor: 3.616

5.  Base sequence differences among the ribonucleic acids of influenza virus.

Authors:  J Content; P H Duesberg
Journal:  J Mol Biol       Date:  1971-12-14       Impact factor: 5.469

6.  Synthesis in vivo of influenza virus plus and minus strand RNA and its preferential inhibition by antibiotics.

Authors:  C Scholtissek; R Rott
Journal:  Virology       Date:  1970-04       Impact factor: 3.616

7.  The RNA of influenza virus.

Authors:  P H Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1968-03       Impact factor: 11.205

8.  The "in vivo" production of "new" influenza A viruses. I. Genetic recombination between avian and mammalian influenza viruses.

Authors:  R G Webster; C H Campbell; A Granoff
Journal:  Virology       Date:  1971-05       Impact factor: 3.616

9.  The metabolism of a poly(A) minus mRNA fraction in HeLa cells.

Authors:  C Milcarek; R Price; S Penman
Journal:  Cell       Date:  1974-09       Impact factor: 41.582

10.  Effect of interferon upon the primary and secondary transcription of vesicular stomatitis and influenza viruses.

Authors:  P Repik; A Flamand; D H Bishop
Journal:  J Virol       Date:  1974-11       Impact factor: 5.103

View more
  4 in total

1.  Cordycepin is a novel chemical suppressor of Epstein-Barr virus replication.

Authors:  Eunhyun Ryu; Myoungki Son; Minjung Lee; Kanghyo Lee; Jae Youl Cho; Sungchan Cho; Suk Kyeong Lee; You Mie Lee; Hyosun Cho; Gi-Ho Sung; Hyojeung Kang
Journal:  Oncoscience       Date:  2014-12-18

Review 2.  Cell Clearing Systems as Targets of Polyphenols in Viral Infections: Potential Implications for COVID-19 Pathogenesis.

Authors:  Fiona Limanaqi; Carla Letizia Busceti; Francesca Biagioni; Gloria Lazzeri; Maurizio Forte; Sonia Schiavon; Sebastiano Sciarretta; Giacomo Frati; Francesco Fornai
Journal:  Antioxidants (Basel)       Date:  2020-11-10

Review 3.  Research Progress on Cordycepin Synthesis and Methods for Enhancement of Cordycepin Production in Cordyceps militaris.

Authors:  Li Wang; Huanhuan Yan; Bin Zeng; Zhihong Hu
Journal:  Bioengineering (Basel)       Date:  2022-02-11

4.  Cordycepin Inhibits Virus Replication in Dengue Virus-Infected Vero Cells.

Authors:  Aussara Panya; Pucharee Songprakhon; Suthida Panwong; Kanyaluck Jantakee; Thida Kaewkod; Yingmanee Tragoolpua; Nunghathai Sawasdee; Vannajan Sanghiran Lee; Piyarat Nimmanpipug; Pa-Thai Yenchitsomanus
Journal:  Molecules       Date:  2021-05-23       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.